| 【Company Research】Innovent Biologics (1801 HK) - Entering sustainable profitability with a global innovation engine |
| 【Company Research】EHang Holdings (EH US) - Obtained the first-ever OC for commercial operations |
| 【Company Research】GAC Group (2238 HK/601238 CH) - Can new management turn around homegrown brands? |
| 【Company Research】Great Wall Motor (2333 HK/601633 CH) - Wey could be key to FY25 earnings growth |
| 【Company Research】Sinotruk (Hong Kong) (3808 HK) - Stay cautious on exports |
| 【Company Research】Xunfei Healthcare (2506 HK) - Accelerated growth in 2H24 solidifies leadership in medical AI |
| 【Company Research】CR MixC Lifestyle (1209 HK) - FY24 earnings dragged by VAS, shopping malls biz kept shining |
| 【Company Research】Yongda Automobiles (3669 HK) - NEV to offset luxury, cost control to drive profit |
| 【Company Research】China Life (2628 HK) - 4Q slowdown as expected; DPS exceeded >50% |
| 【Company Research】BOE Varitronix (710 HK) - FY24 strong sales dragged by weaker margin; system biz and overseas expansion as next growth drivers |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
